role of p2y12 inhibitor therapy in acs and after pci: twilight and isar-react 5
Published Streamed 2 years ago • 316 plays • Length 1:07:18Download video MP4
Download video MP3
Similar videos
-
2:07:46
ticagrelor and acs. apsc cme series
-
50:17
iscp 2021 - interventional pharmacology: walking the tightrope of ischemia and bleeding
-
9:27
dr. lopes on augustus trial: apixaban and p2y12 inhibitor without asa is enough in post-pci afib
-
2:01:18
"utilizing potent p2y12 inhibitor for post-pci patients"
-
1:12:36
unusual causes and complications of acute coronary syndromes. fellows teaching course: save-a-life!
-
49:53
iscp 2021 - precision medicine in the use of antithrombotics: fact or fiction?
-
26:26
2020 esc guidelines on non-st-segment elevation acute coronary syndromes. esc asia. 4th dec 2020
-
1:55:38
decision-making in primary interventional therapy of acute coronary syndrome.(part i). 4th nov 2020
-
1:01:51
all about aspirin. iscp’s a to z of cv pharmacotherapy series
-
2:03:37
imaging from simple to complex pci- live transmission
-
1:23:46
treatment of worsening heart failure in asia pacific
-
2:02:02
scs-qicc joint session: case based a-z for complex pci
-
1:11:45
antithrombotic regime in af patients undergoing pci. apsc journal club series
-
2:21:55
use of intravascular imaging in ami
-
1:19:46
apsc-eecc core cardiology review series season 2 | valvular heart disease
-
55:02
iscp 2021 - the role of telemedicine and cardiovascular pharmacotherapy
-
1:06:11
iscp 2021 dapagliflozin et al. the growing therapeutic spectrum of sglt2i
-
1:55:25
tacs & apsc complex lm interventions